Clinical and Quality-of-life Outcomes Following Gland-preserving Surgery for Chronic Sialadenitis
Overview
Authors
Affiliations
Objectives/hypothesis: Gland-preserving salivary surgery utilizing salivary endoscopy has been proposed as a treatment alternative in the management of chronic sialadenitis. This study seeks to determine medium-term clinical and quality-of-life (QOL) outcomes following a gland-preserving approach for chronic sialadenitis.
Study Design: Cross-sectional survey with retrospective chart review.
Methods: All patients undergoing attempted gland-preserving salivary surgery with salivary endoscopy for chronic sialadenitis at a tertiary, academic salivary referral center between October 2008 and April 2013 were identified from a quality assurance database. A research database was constructed to examine clinical factors of interest. A clinical outcomes and QOL survey was mailed to all eligible patients in order to obtain long-term follow-up data.
Results: A total of 206 of 306 (67%) eligible patients returned the survey. The median length of follow-up was 17 months (3-54 months). The majority of patients (89%) endorsed symptom improvement after gland-preserving therapy. Surgical excision was performed on 8% of affected glands. Patients with chronic sialadenitis due to stones reported a greater incidence of symptom resolution (P = 0.0004) and more favorable QOL outcomes (P = 0.0001) than patients with nonstone etiologies.
Conclusions: Patients undergoing gland-preserving salivary surgery with salivary endoscopy for chronic sialadenitis have favorable long-term symptom improvement and gland retention rates. Although patients with stones demonstrated the best outcomes, improvement was documented for all etiologies of chronic sialadenitis.
Level Of Evidence: 4.
Chang C, Wang H Laryngoscope Investig Otolaryngol. 2023; 8(1):76-81.
PMID: 36846401 PMC: 9948575. DOI: 10.1002/lio2.1007.
Development of a patient reported outcome instrument for chronic sialadenitis.
Ramazani F, Hamour A, Jeffery C, Biron V, Alrajhi Y, OConnell D J Otolaryngol Head Neck Surg. 2022; 51(1):4.
PMID: 35120574 PMC: 8815140. DOI: 10.1186/s40463-022-00555-z.
Christou A, Papastavrou E, Merkouris A, Charalambous A SAGE Open Med. 2021; 9:20503121211042211.
PMID: 34484788 PMC: 8414619. DOI: 10.1177/20503121211042211.
Botulinum toxin for chronic parotid sialadenitis: A case series and systematic review.
Strohl M, Chang C, Ryan W, Chang J Laryngoscope Investig Otolaryngol. 2021; 6(3):404-413.
PMID: 34195360 PMC: 8223475. DOI: 10.1002/lio2.558.
Lommen J, Schorn L, Roth B, Naujoks C, Handschel J, Holtmann H Head Face Med. 2021; 17(1):8.
PMID: 33648547 PMC: 7919083. DOI: 10.1186/s13005-021-00259-1.